Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene selection from microarray data for cancer classification--a machine learning approach.

Yu Wang1, Igor V Tetko, Mark A Hall

  • 1Institute for Bioinformatics, German Research Center for Environment and Health, Ingolstädter Landstrasse 1, D-85764 Neuherberg, Germany. yu.wang@gsf.de

Computational Biology and Chemistry
|February 1, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and Use of a Population Pharmacokinetic Model for Characterizing the Pharmacokinetics of Vonoprazan in Pediatric Patients.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Experiments with optimal model trees.

Scientific reports·2026
Same author

Extensive variation between chromosomes of North American and European hop.

Nature communications·2026
Same author

SangsterLogP - the largest publicly available dataset of logP values.

Scientific data·2026
Same author

The pharmacokinetics and safety of vonoprazan in adolescents and children with gastroesophageal reflux disease.

Journal of pediatric gastroenterology and nutrition·2026
Same author

A revised classification of FVIII concentrates: rationale and novel metrics.

Blood advances·2026
Same journal

Role of Artificial Intelligence in bioinformatics: Revolutionizing molecular docking and DNA tokenization.

Computational biology and chemistry·2026
Same journal

An interpretable framework for cancer drug response prediction using integrated drug and multi-omics data with a hybrid Bi-LSTM-GRU network.

Computational biology and chemistry·2026
Same journal

SegMWB: A lightweight deep learning framework for microscopic image classification.

Computational biology and chemistry·2026
Same journal

Protein dynamic simulations: From early inception to clinical translation over half a century.

Computational biology and chemistry·2026
Same journal

Integrated omics and virtual screening predict Tabularin as a dual inhibitor of the prognostic microRNAs mir-19a and mir-32 in colorectal cancer.

Computational biology and chemistry·2026
Same journal

In silico characterization of acetyl-CoA carboxylase from Staphylococcus aureus and Escherichia coli: A comparative analysis.

Computational biology and chemistry·2026
See all related articles

This study developed feature selection algorithms to identify key genes in cancer microarray data. These methods effectively classify cancers like leukemia and lymphoma, aiding in understanding disease mechanisms.

Area of Science:

  • Genomics
  • Bioinformatics
  • Cancer Research

Background:

  • DNA microarrays enable simultaneous tracking of thousands of gene expression levels.
  • Microarray technology has shown promise in cancer classification.
  • Cancer microarray datasets typically feature numerous genes (features) and few samples, posing a dimensionality challenge.

Purpose of the Study:

  • To systematically investigate feature selection algorithms for extracting gene information from cancer microarray data.
  • To reduce the dimensionality of cancer microarray data.
  • To identify relevant genes associated with different cancer types.

Main Methods:

  • Employed a correlation-based feature selector.
  • Integrated machine learning algorithms including decision trees, Naïve Bayes, and support vector machines.

Related Experiment Videos

  • Applied these methods to acute leukemia and diffuse large B-cell lymphoma microarray datasets.

    • Main Results:

    • Achieved classification performance comparable to or better than published results on leukemia and lymphoma data.
    • Demonstrated that combining different classification and feature selection approaches enhances the confidence in selecting relevant genes.
    • Provided the first evidence, both computational and biological, for zyxin's role in leukaemogenesis.

    Conclusions:

    • Feature selection algorithms combined with machine learning are effective for cancer classification using microarray data.
    • A hybrid approach to feature selection and classification increases the reliability of identifying key genes.
    • Identified zyxin as a potentially significant factor in leukaemogenesis, supported by novel evidence.